Vaxart Analyst Ratings
Vaxart Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
12/19/2022 | 41.51% | B. Riley Securities | $6 → $1.5 | Maintains | Neutral |
09/02/2022 | 654.72% | Cantor Fitzgerald | $11 → $8 | Maintains | Overweight |
05/19/2022 | 466.04% | B. Riley Securities | $7 → $6 | Maintains | Neutral |
11/02/2021 | 1315.09% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
06/30/2021 | 749.06% | B. Riley Securities | $13 → $9 | Downgrades | Buy → Neutral |
06/24/2021 | 1126.42% | Jefferies | → $13 | Initiates Coverage On | → Buy |
06/11/2021 | 1598.11% | Piper Sandler | → $18 | Initiates Coverage On | → Overweight |
08/12/2020 | 1503.77% | HC Wainwright & Co. | $7 → $17 | Maintains | Buy |
07/13/2020 | 1975.47% | B. Riley Securities | → $22 | Initiates Coverage On | → Buy |
04/30/2020 | 560.38% | HC Wainwright & Co. | $3 → $7 | Reiterates | → Buy |
06/27/2019 | 88.68% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
12/19/2022 | 41.51% | B.萊利證券 | $6 → $1.5 | 維護 | 中性 |
09/02/2022 | 654.72% | 康託·菲茨傑拉德 | $11 → $8 | 維護 | 超重 |
05/19/2022 | 466.04% | B.萊利證券 | $7 → $6 | 維護 | 中性 |
11/02/2021 | 1315.09% | 康託·菲茨傑拉德 | → $15 | 開始承保 | →超重 |
06/30/2021 | 749.06% | B.萊利證券 | $13 → $9 | 評級下調 | 購買→中性 |
06/24/2021 | 1126.42% | 傑富瑞 | → $13 | 開始承保 | →購買 |
06/11/2021 | 1598.11% | 派珀·桑德勒 | → $18 | 開始承保 | →超重 |
08/12/2020 | 1503.77% | HC Wainwright公司 | $7 → $17 | 維護 | 買 |
07/13/2020 | 1975.47% | B.萊利證券 | → $22 | 開始承保 | →購買 |
04/30/2020 | 560.38% | HC Wainwright公司 | $3 → $7 | 重申 | →購買 |
06/27/2019 | 88.68% | HC Wainwright公司 | → $2 | 開始承保 | →購買 |
What is the target price for Vaxart (VXRT)?
Vaxart(VXRT)的目標價是多少?
The latest price target for Vaxart (NASDAQ: VXRT) was reported by B. Riley Securities on December 19, 2022. The analyst firm set a price target for $1.50 expecting VXRT to rise to within 12 months (a possible 41.51% upside). 3 analyst firms have reported ratings in the last year.
B·萊利證券於2022年12月19日報道了瓦克沙特(納斯達克:VXRT)的最新目標價。這家分析公司將目標價定為1.50美元,預計VXRT將在12個月內上漲(可能上漲41.51%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Vaxart (VXRT)?
Vaxart(VXRT)最近的分析師評級是多少?
The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by B. Riley Securities, and Vaxart maintained their neutral rating.
納斯達克(Sequoia Capital:VXRT)的最新分析師評級由B.Riley Securities提供,Vaxart維持中性評級。
When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?
Vaxart(VXRT)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on December 19, 2022 so you should expect the next rating to be made available sometime around December 19, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查看公開的財務報表,與Vaxart的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Vaxart的上一次評級是在2022年12月19日提交的,因此您應該預計下一次評級將在2023年12月19日左右提供。
Is the Analyst Rating Vaxart (VXRT) correct?
分析師評級Vaxart(VXRT)正確嗎?
While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a maintained with a price target of $6.00 to $1.50. The current price Vaxart (VXRT) is trading at is $1.06, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Vaxart(VXRT)評級維持不變,目標價在6.00美元至1.50美元之間。Vaxart(VXRT)目前的交易價格為1.06美元,超出了分析師的預測區間。